LIQTECH INTERNATIONAL INC annual report, FY2016

LiqTech International, Inc. — FY2016 Form 10-K

Reporting period: Fiscal year ended December 31, 2016. This is an annual report, not a standalone fourth-quarter report; the company recorded a material goodwill impairment during its fourth-quarter 2016 annual test.

Business context

LiqTech develops and manufactures silicon-carbide ceramic filters and integrated filtration systems. Its principal businesses are liquid filtration and diesel particulate filters (DPFs); kiln-furniture sales are being phased out. Liquid filtration serves water-treatment, industrial, mining, marine, and oil-and-gas applications. DPFs serve retrofit and OEM markets. Operations are based in Denmark and the United States.

Key financial results

MetricFY2016FY2015
Net sales$13.91 million$15.81 million
Gross profit / margin$1.43 million / 10.3%$3.21 million / 20.3%
Operating loss$13.13 million$3.40 million
Net loss attributable to LiqTech$16.42 million$2.21 million
Loss per share, basic and diluted$0.45$0.06
Cash from (used in) operations$0.42 million($2.09 million)
Cash used in investing$0.37 million$0.59 million
Cash used in financing$0.20 million$0.22 million

At December 31, 2016, cash was $1.21 million, working capital was $3.50 million, total assets were $11.41 million, and total liabilities were $5.14 million. Notes payable totaled approximately $55,000; capital-lease obligations totaled approximately $140,000. The company reported no general-purpose available credit lines. Operating lease commitments were $1.59 million.

Reported 2016 cash flow from operations includes substantial noncash adjustments, including goodwill impairment, deferred taxes, bad debt expense, and inventory reserves; it should not be read as evidence of profitable operations.

Changes versus prior year

  • Revenue fell 12.1%. Liquid-filter sales declined $2.62 million, partly offset by a $0.74 million increase in DPF sales; kiln-furniture sales declined $0.03 million.
  • Gross margin fell 10 percentage points, reflecting lower sales activity and a higher obsolete-inventory reserve.
  • Operating expenses rose to $14.57 million, principally because of a $7.34 million goodwill impairment and higher general and administrative costs. G&A included a $1.44 million bad-debt provision.
  • Net loss widened to $16.42 million. The company also recorded $3.22 million of income-tax expense, including a significant valuation-allowance impact.
  • Customer concentration increased: the four largest customers represented about 67% of 2016 sales, versus 56% in 2015.
  • Goodwill, previously $7.58 million, was fully written off in 2016. The company also canceled 2,696,521 escrowed acquisition shares after LiqTech Systems failed to meet specified revenue and EBITDA milestones.

Liquidity, outlook, and risks

The auditor and management stated that limited cash and significant losses raise substantial doubt about LiqTech’s ability to continue as a going concern. The company expected a proposed $4 million investment from Hunan Yonker Investment Group by April 15, 2017; regulatory delays had already led to an extension. If the investment was not completed, LiqTech said it would need to seek debt or equity financing, with no assurance financing would be available on acceptable terms or at all; absent funding, it could reduce or curtail operations. No quantitative revenue or earnings guidance is provided.

  • Management cited delayed liquid-filtration opportunities and a longer-than-expected sales cycle. Large orders and customer shipment timing can fluctuate, and purchase orders may be canceled or delayed with limited penalties.
  • Major-customer and receivables concentration, including customer credit risk, are material concerns. Receivables are not collateralized or credit-insured.
  • Other risks include limited silicon-carbide and precious-metal supply, dependence on subcontract manufacturing capacity, foreign-currency exposure, competition, regulatory changes, and environmental or product-liability claims.
  • A lawsuit in Italy seeks €750,000 over alleged defective products supplied to a joint venture. The company disputes the claim; the matter was at a preliminary expert-review stage, with an outcome not yet clear.

Developments and unusual items

  • A $7.34 million goodwill impairment eliminated the remaining goodwill balance; it was a noncash charge.
  • 2016 orders and agreements included groundwater-treatment work in Serbia, DPF supply orders for Kailong in China, and water-treatment systems for DuPont and a Danish power-plant equipment supplier. Some announced opportunities were conditional or milestone-based and are not equivalent to recognized revenue.
  • The proposed Kailong China arrangement included a $2 million technology payment and royalties, subject to agreement terms and milestones. The Yonker equity investment and joint venture remained subject to regulatory and other conditions.
  • Government grants were $158,000 in 2016, down from $797,000 in 2015. Research and development spending was $626,000, versus $708,000.
  • Management reported effective disclosure controls and internal control over financial reporting. The auditor’s opinion was unmodified but included a going-concern emphasis.

Most important facts for investors to verify

  • Whether the proposed $4 million Yonker investment closed by the extended April 15, 2017 deadline, and what financing or operating actions followed.
  • Current cash availability and the precise restricted-cash position: the balance sheet reports no restricted cash at year-end, while a footnote refers to $292,826 restricted to secure guarantees.
  • Whether customer collections, bad-debt exposure, and the $2.13 million doubtful-account allowance were adequate, particularly for the largest customers.
  • Conversion of announced orders, letters of intent, and joint-venture arrangements into funded contracts, deliveries, and collected cash.
  • The financial and operational consequences of the full goodwill impairment, weak gross margin, and inventory-obsolescence reserve.
  • Subsequent developments in the Italian €750,000 claim and any related contingency disclosures.